Effect of morphine on cerebral activity of extremely premature infants

Miriam Peled1, Avishag Abuhatzira1, Lena Novack2

  • 1Ben Gurion University of the Negev, Faculty of Health Sciences, Israel; Soroka Medical Center, Neonatal Department, Israel.

Early Human Development
|November 1, 2020
PubMed

Insights

Morphine sedation in premature infants significantly depresses cerebral activity. Amplitude-integrated electroencephalography (aEEG) showed worsened background activity and loss of cycling within hours of morphine initiation.

Area of Science:

  • Neonatal Neuroscience
  • Clinical Neurophysiology

Background:

  • Morphine is commonly used for sedation in extremely preterm infants.
  • Potential long-term neurodevelopmental effects of morphine are a concern.

Purpose of the Study:

  • To evaluate the immediate impact of morphine on cerebral activity in extremely preterm infants.
  • To assess changes in background activity and cycling patterns on amplitude-integrated electroencephalography (aEEG).

Main Methods:

  • Retrospective analysis of 140 infants < 28 weeks gestational age (GA).
  • Continuous monitoring using aEEG for 12 hours, including baseline and 6 consecutive 2-hour periods after morphine initiation.
  • Assessment of background activity score and presence of cycling.

Main Results:

  • Background aEEG activity worsened in 40% of infants by 6 hours.
  • Cycling, initially present in 70%, was detected in only 10% after 10 hours.
  • Morphine administration was associated with a significant decrease in background activity and increased risk of cycling loss.

Conclusions:

  • Continuous morphine infusion significantly depresses cerebral activity in extremely preterm infants shortly after administration.
  • Findings highlight the need for careful monitoring of cerebral function during morphine sedation in this vulnerable population.
Abstract

Related Concept Videos

Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
717
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
639
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.7K